Research Projects

This database contains information on EU funded dementia research projects, undertaken since 2007. It is the product of a mapping exercise of European funding programmes for dementia research conducted by Alzheimer Europe in 2020. This database is not an exhaustive resource of information. It contains information about dementia research projects that are funded by European programmes including FP7, H2020, IMI, JPND, AAL and the third EU Health programme. The mapping exercise and database were expanded in 2025, to include projects funded under Horizon Europe (including IHI). For these projects, the database reports the maximum contribution from the European Commission rather than the total project budget, so funding figures may not be directly comparable across all entries.
For an overview of projects, Alzheimer Europe is involved in, visit: https://www.alzheimer-europe.org/our-work/current-work

Filters

(Clear all)

MED-GUIDE

MED-GUIDE

MedGUIDE is a European innovation project that provides an innovative approach to support seniors with dementia with their medication adherence through smart pill boxes and social networking. The project aims to help elders with mild cognitive impairments living at home

Funding Programme
Start Date
End Date
Total Funding
€ 2 039 024
European Countries Involved

Membrane protein aggregation and its links with neurodegenerative diseases

MPA-ND

Protein aggregation is associated with some of the most prevalent and devastating neurodegenerative disorders in our society, including Alzheimer’s and Parkinson’s diseases. The intricate details of the aggregation process are now beginning to emerge through major efforts for characterizing the associated protein deposits . However, knowledge about...

Funding Programme
Start Date
End Date
Total Funding
€ 183 455
European Countries Involved

Membrane-active peptides across disciplines and continents: An integrated approach to find new strategies to fight bacteria, dengue virus and neurodegeneration

MEMPEPACROSS

Peptide-lipid interactions are critical in several biomedical matters that seem uncorrelated at a first glance. MEMPEPACROSS deals with some of these: 1) Lipid membrane-interactions are the key for the understanding of dengue virus assembly and can constitute a target for its inhibition. Viral hemorrhagic fever caused by dengue virus is a serious...

Funding Programme
Start Date
End Date
Total Funding
€ 181 800
European Countries Involved

MEMENTO – A persuasive system supporting Memory and Moments of people with Early and Middle stage of dementia

MEMENTO

MEMENTO provides a solution to help people with dementia to life with a decline of memory – short term memory as well as long term memory. MEMENTO provides a tool to create own set of memories in everyday life. It’s your own picture, voice and video diary. MEMENTO addresses people with early and middle level of dementia such as those subjects with...

Funding Programme
Start Date
End Date
Total Funding
€ 2 104 752
European Countries Involved

Memory Enhancing and Learning System

MEMBOOST

Advances in neuroscience have returned the focus on learning, placing the relationship between sleep and consolidation of memory at the centre of academic debate. There are two types of sleep: rapid eye movements and slow wave sleep (SWS). Although both types of sleep have been related to memory consolidation, accumulated evidence points more to...

Funding Programme
Start Date
End Date
Total Funding
€ 71 429
European Countries Involved

Memory loss in Alzheimer disease: underlying mechanisms and therapeutic targets

MEMOSAD

MEMOSAD aims at defining the molecular mechanisms of Abeta- and Tau-induced synaptotoxicity and at developing disease-modifying therapeutics for the prevention of memory loss in Alzheimer disease (AD). Insoluble aggregates of the two proteins provide the pathological hallmarks of this incurable brain disorder. Early stage AD is characterized by a...

Funding Programme
Start Date
End Date
Total Funding
€ 4 023 080
European Countries Involved

Memory research: Ground-breaking, Applied, and Technological Exchanges

M-GATE

In M-GATE, ESRs will combine state-of-the art experimental neurophysiology, innovative technologies, and advanced theoretical approaches to unveil memory mechanisms, from single neurons to brain networks, to cognition and behaviour, addressing the healthy and diseased brain. Through research and training from top-class scientists and close...

Funding Programme
Start Date
End Date
Total Funding
€ 3 961 160
European Countries Involved

METABOLIC BASIS OF NEURODEGENERATIVE DISEASE

BEYOND

Alzheimer disease (AD) is the most common form of age-related dementia affecting millions of patients worldwide. Disturbingly, disorders of lipid and glucose metabolism emerge as major risk factors for onset and progression of neurodegeneration in the human population. Thus, an increasing life expectance combined with an observable rise in...

Funding Programme
Start Date
End Date
Total Funding
€ 2 415 229
European Countries Involved

Metaphorical Narratives in Dementia Discourse

MeNDD

Research on dementia discourse has shown how our attitudes, views and words have a positive or negative influence on the well-being of People Living With Dementia (PLWD). In 2013, Alzheimer Europe’s report underlined worrying ethical risks of metaphor use in dementia narratives, including stigmatisation, stereotyping and social exclusion. Yet we...

Funding Programme
Start Date
End Date
Total Funding
€ 175 572
European Countries Involved

MI-Tale – A personalised psychobiographic game to access and preserve memories of people with dementia.

MI-TALE

Memories are important for dementia patients; they influence how they act and feel nowadays. However, for people around them, it is often hard to explore what is really going on in their beloved one’s mind. In MI-Tale we develop a digital and interactive game to recall and record memories. This tool contains existing material such as historical...

Funding Programme
Start Date
End Date
Total Funding
€ 1 001 627
European Countries Involved

Microbiome-Microglia interaction in Alzheimer's disease

MiMi-AD

Alzheimer’s disease (AD) affects over 55 million people worldwide, with no effective treatments currently available. Understanding early-stage mechanisms of the disease is critical to developing new therapeutic approaches. Microglial cells, key regulators of amyloid-beta (Aβ) clearance and neuroinflammation, are implicated in the progression of AD...

Funding Programme
Start Date
End Date
Total Funding
€ 226 420
European Countries Involved

MIcrobiota-Gut-BraiN EngineeRed platform to eVAluate intestinal microflora impact on brain functionality

MINERVA

What is the relation between the intestinal microflora and the brain in the development of neurodegenerative disorders like Alzheimer's and Parkinson's disease? A functional relation between the intestinal microflora (microbiota) and the brain, referred to as the “microbiota-gut-brain axis”, was hypothesized more than 100 years ago but only...

Funding Programme
Start Date
End Date
Total Funding
€ 1 999 194
European Countries Involved
 
Acknowledgement
Alzheimer Europe's database on research projects was developed as part of the 2020 Work Plan which received funding under an operating grant from the European Union’s Health Programme (2014–2020).